Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Childhood acute lymphoblastic leukemia in the Middle East and neighboring countries: a prospective multi-institutional international collaborative study (CALLME1) by the Middle East Childhood Cancer Alliance (MECCA).

Al-Mulla NA, Chandra P, Khattab M, Madanat F, Vossough P, Torfa E, Al-Lamki Z, Zain G, Muwakkit S, Mahmoud S, Al-Jassmi A, Tuncer M, Al-Mukharraq H, Barsaoui S, Arceci RJ, Howard SC, Kulozik AE, Ravindranath Y, Reaman GH, Farranoush M, AlNasser AA.

Pediatr Blood Cancer. 2014 Aug;61(8):1403-10. doi: 10.1002/pbc.25031.

PMID:
24648275
2.

Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia in Saudi Arabia: a multi-institutional retrospective national collaborative study.

Al-Sudairy R, Al-Nasser A, Alsultan A, Al Ahmari A, Abosoudah I, Al-Hayek R, Al-Harbi T, Al-Manjomi F, Al-Harbi M, Al-Ghamdi H, Al-Shahrani M, Belgaumi AF.

Pediatr Blood Cancer. 2014 Jan;61(1):74-80. doi: 10.1002/pbc.24584.

PMID:
23940019
3.

Frequencies of ETV6-RUNX1 fusion and hyperdiploidy in pediatric acute lymphoblastic leukemia are lower in far east than west.

Liang DC, Shih LY, Yang CP, Hung IJ, Liu HC, Jaing TH, Yeh TC, Liang ST, Chang CL, Lee EH, Lai CL, Chang WH.

Pediatr Blood Cancer. 2010 Sep;55(3):430-3. doi: 10.1002/pbc.22628.

PMID:
20658612
4.

Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocol.

Gandemer V, Chevret S, Petit A, Vermylen C, Leblanc T, Michel G, Schmitt C, Lejars O, Schneider P, Demeocq F, Bader-Meunier B, Bernaudin F, Perel Y, Auclerc MF, Cayuela JM, Leverger G, Baruchel A; FRALLE Group..

Haematologica. 2012 Nov;97(11):1743-50. doi: 10.3324/haematol.2011.059584.

5.

Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California.

Aldrich MC, Zhang L, Wiemels JL, Ma X, Loh ML, Metayer C, Selvin S, Feusner J, Smith MT, Buffler PA.

Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):578-81.

6.

Outcome of ETV6/RUNX1-positive childhood acute lymphoblastic leukaemia in the NOPHO-ALL-1992 protocol: frequent late relapses but good overall survival.

Forestier E, Heyman M, Andersen MK, Autio K, Blennow E, Borgström G, Golovleva I, Heim S, Heinonen K, Hovland R, Johannsson JH, Kerndrup G, Nordgren A, Rosenquist R, Swolin B, Johansson B; Nordic Society of Paediatric Haematology, Oncology (NOPHO).; Swedish Cytogenetic Leukaemia Study Group (SCLSG).; NOPHO Leukaemia Cytogenetic Study Group (NLCSG)..

Br J Haematol. 2008 Mar;140(6):665-72. doi: 10.1111/j.1365-2141.2008.06980.x.

PMID:
18241254
7.

ETV6/RUNX1 fusion lacking prognostic effect in pediatric patients with acute lymphoblastic leukemia.

Zen PR, Capra ME, Silla LM, Loss JF, Fernandes MS, Jacques SM, Paskulin GA.

Cancer Genet Cytogenet. 2009 Jan 15;188(2):112-7. doi: 10.1016/j.cancergencyto.2008.09.005.

PMID:
19100516
8.

Prevalence of ETV6-RUNX1 fusion gene in children with acute lymphoblastic leukemia in China.

Gao YJ, Zhu XH, Yang Y, Wu Y, Lu FJ, Zhai XW, Wang HS.

Cancer Genet Cytogenet. 2007 Oct 1;178(1):57-60.

PMID:
17889709
9.

Clinical features and induction outcome of childhood acute lymphoblastic leukemia in a lower/middle income population: A multi-institutional report from Pakistan.

Fadoo Z, Nisar I, Yousuf F, Lakhani LS, Ashraf S, Imam U, Zaheer J, Naqvi A, Belgaumi A.

Pediatr Blood Cancer. 2015 Oct;62(10):1700-8. doi: 10.1002/pbc.25583.

PMID:
25982135
10.

Five most common prognostically important fusion oncogenes are detected in the majority of Pakistani pediatric acute lymphoblastic leukemia patients and are strongly associated with disease biology and treatment outcome.

Awan T, Iqbal Z, Aleem A, Sabir N, Absar M, Rasool M, Tahir AH, Basit S, Khalid AM, Sabar MF, Asad S, Ali AS, Mahmood A, Akram M, Saeed T, Saleem A, Mohsin D, Shah IH, Khalid M, Asif M, Haq R, Iqbal M, Akhtar T.

Asian Pac J Cancer Prev. 2012;13(11):5469-75.

11.

Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group.

Borkhardt A, Cazzaniga G, Viehmann S, Valsecchi MG, Ludwig WD, Burci L, Mangioni S, Schrappe M, Riehm H, Lampert F, Basso G, Masera G, Harbott J, Biondi A.

Blood. 1997 Jul 15;90(2):571-7.

12.

TEL-AML1 fusion transcript in relapsed childhood acute lymphoblastic leukemia. The Berlin-Frankfurt-Münster Study Group.

Seeger K, Adams HP, Buchwald D, Beyermann B, Kremens B, Niemeyer C, Ritter J, Schwabe D, Harms D, Schrappe M, Henze G.

Blood. 1998 Mar 1;91(5):1716-22.

13.

Hemophagocytosis by leukemic blasts in B lymphoblastic leukemia with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1): a case report.

Park JE, Park IJ, Lim YA, Lee WG, Cho SR.

Ann Clin Lab Sci. 2013 Spring;43(2):186-9.

PMID:
23694795
14.

CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia.

Roman-Gomez J, Jimenez-Velasco A, Agirre X, Castillejo JA, Navarro G, Calasanz MJ, Garate L, San Jose-Eneriz E, Cordeu L, Prosper F, Heiniger A, Torres A.

Clin Cancer Res. 2006 Aug 15;12(16):4845-50.

15.

Analysis of ETV6/AML1 abnormalities in acute lymphoblastic leukaemia: incidence, alternative spliced forms and minimal residual disease value.

Codrington R, O'Connor HE, Jalali GR, Carrara P, Papaioannou M, Hart SM, Hoffbrand AV, Potter M, Prentice HG, Harrison CJ, Foroni L.

Br J Haematol. 2000 Dec;111(4):1071-9.

PMID:
11167742
16.

Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.

Ribera JM, Ortega JJ, Oriol A, Granada I, Hernández-Rivas JM, Parody R, Bethencourt C, Rivas C, Bastida P, del Potro E, González-Valentín ME, Moreno MJ, Besalduch J, Fernández-Calvo J, Tormo M, Arias J, Molinés A, Sanz MA, Maldonado J, Millá F, Feliu E, San Miguel JF; PETHEMA Group, Spanish Society of Hematology..

Haematologica. 2002 Feb;87(2):154-66.

17.

Cytogenetic characterization of childhood acute lymphoblastic leukemia in Nicaragua.

Ceppi F, Brown A, Betts DR, Niggli F, Popovic MB.

Pediatr Blood Cancer. 2009 Dec 15;53(7):1238-41. doi: 10.1002/pbc.22169.

PMID:
19672974
18.
19.

In search of Pinkel's children: unravelling the biological heterogeneity of childhood acute lymphoblastic leukaemia by genotype and treatment molecular response.

Krawczyk J, Maguire S, Sandys N, Kelly J, Ryan C, O'Marcaigh A, Storey L, Rooney S, Phillips C, Smith OP.

Ir J Med Sci. 2013 Sep;182(3):377-82. doi: 10.1007/s11845-012-0892-8.

PMID:
23242576
20.

Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukemia and their association with disease biology and outcome.

Sabir N, Iqbal Z, Aleem A, Awan T, Naeem T, Asad S, Tahir AH, Absar M, Hasanato RM, Basit S, Chishti MA, Faiyaz Ul-Haque M, Khalid AM, Sabar MF, Rasool M, Karim S, Khan M, Samreen B, Akram AM, Siddiqi MH, Shahzadi S, Shahbaz S, Ali AS, Mahmood A, Akram M, Saeed T, Saleem A, Mohsin D, Shah IH, Khalid M, Asif M, Iqbal M, Akhtar T.

Asian Pac J Cancer Prev. 2012;13(7):3349-55.

Items per page

Supplemental Content

Support Center